INTELLECT NEUROSCI COM USD0.001 (ILNS)

0.02
OTC Markets
Prev Close 0.02
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.01 / 0.14
Exchange OTC Markets
Shares Outstanding 6.52B
Market Cap 104.30K
Div & Yield N.A. (N.A)

Latest News

Intellect Neurosciences Adds Two New Tau Programs To Its Alzheimer's Disease Development Pipeline

Intellect Neurosciences Adds Two New Tau Programs To Its Alzheimer's Disease Development Pipeline

Company Obtains Exclusive License from Northwestern University for Therapeutic and Diagnostic Antibodies Targeting Earliest Neurotoxic Forms of Tau Protein

Intellect Neurosciences Receives Notice Of Allowance From United States Patent And Trademark Office For Its ANTISENILIN® Alzheimer's Disease Immunotherapy Technology Platform

Intellect Neurosciences Receives Notice Of Allowance From United States Patent And Trademark Office For Its ANTISENILIN® Alzheimer's Disease Immunotherapy Technology Platform

USPTO allows claims directed to methods of treating Alzheimer's disease using therapeutic antibodies that recognize the free C-terminus of Beta Amyloid 1-40

Intellect Neurosciences Responds To Official Action By United States Patent And Trademark Office In Relation To Its ANTISENILIN® Alzheimer's Patent Application

Intellect application supported by written declaration from independent, world renowned academic expert in therapeutic antibodies

Intellect Neurosciences Announces Its New CONJUMAB-A Platform Technology For Novel Treatments Of Alzheimer's Disease And Other Proteinopathies

New platform of antibody drug conjugates to deliver potent cytoprotective drugs to sites of amyloidosis in brain and other organs